Tsianakas A, et al. - This clinical trial was conducted to determine the effects of dupilumab in the treatment of moderate-to-severe atopic dermatitis. Authors also assessed the impact of this treatment on the quality of life of the subjects. Results revealed that dupilumab was a new breakthrough treatment for atopic dermatitis and was well-tolerated. It was seen to be effective in the treatment of eczema and its symptoms, hence improving the quality of life of the patients.